TLIS News and Press, Talis Biomedical Corporation From 08/02/23

REDWOOD CITY, Calif., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care (POC), today announce...

Preliminary data suggest a chlamydia, gonorrhea and trichomonas (CT/NG/TV) multiplex test is feasible on a molecular point-of-care (POC) test system with time to result in less than 30 minutes Ability to effectively lyse challenging fungal pathogens, including Candida, in under four min...

2023-07-24 08:13:19 ET Diagnostic company Talis Biomedical ( NASDAQ: TLIS ) said on Monday that it has regained compliance with Nasdaq's minimum bid price requirement of at least $1.00 per share. The news comes after Talis Biomedical announced a 1-for-15 reverse stock s...

REDWOOD CITY, Calif., July 24, 2023 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care, today announced that...

2023-07-05 08:21:57 ET Diagnostic company Talis Biomedical ( NASDAQ: TLIS ) said on Wednesday that it will effect a 1-for-15 reverse stock split at 5:00 PM ET today to increase the value of its shares. The shares will begin trading on a reverse stock split adjusted basis from ...

REDWOOD CITY, Calif., July 05, 2023 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care, today announced that...

REDWOOD CITY, Calif., May 23, 2023 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care, today announced Heine...

2023-05-14 10:58:02 ET Talis Biomedical Corporation (TLIS) Q1 2023 Earnings Conference Call May 11, 2023 04.30 PM ET Company Participants Emily Faucette - Senior Vice President, Corporate Communications & Investor Relations Rob Kelley - Chief Executive Officer ...

2023-05-11 16:36:01 ET Talis Biomedical press release ( NASDAQ: TLIS ): Q1 Net loss was $17.8M. Revenue of $1.2M (-62.5% Y/Y) beats by $0.95M . Shares -2.74% . For further details see: Talis Biomedical reports Q1 results

REDWOOD CITY, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care, today announced a bus...